Peptide API Batch Record Review: A Guide for Procurement and QA

In the pharmaceutical and biotechnology industries, the review of peptide API batch records is a critical step in supplier qualification and ongoing quality oversight. Procurement and QA professionals must understand what a batch record contains and how to assess its completeness and accuracy. This article provides a structured approach to conducting a peptide API batch record review, focusing on key documents and red flags. By mastering this process, teams can mitigate risks and ensure that the peptide API meets regulatory expectations.

A peptide API batch record is a compilation of documents generated during the manufacturing of a specific lot. It typically includes the master batch record, executed batch record, raw material certificates of analysis, in-process control results, and final release testing data. The batch record provides a complete history of the manufacturing process, from raw material dispensing to final packaging. For procurement and QA, reviewing these records helps verify that the supplier followed established procedures and that the API meets predetermined specifications.

When reviewing a batch record, start by checking the master batch record to ensure it is approved and current. Then, compare the executed batch record against the master to identify any deviations. Deviations should be documented, investigated, and appropriately resolved. Look for missing signatures, dates, or incomplete fields. In-process control results, such as pH, temperature, and reaction times, should fall within defined ranges. Any out-of-specification results must have a corresponding investigation and conclusion. This step is crucial for confirming process consistency.

Raw material certificates of analysis are another key component. Verify that all raw materials used in the batch were approved and met specifications. Check that the suppliers of raw materials are qualified and that certificates are traceable to the batch. For critical raw materials, such as amino acids and resins, ensure that the certificates include appropriate analytical data. This review helps prevent the use of substandard materials that could compromise the final API quality.

Final release testing data should include results for identity, purity, and potency, as well as any other tests specified in the regulatory filing. Compare the results to the specifications in the certificate of analysis. Ensure that the testing methods are validated and that the equipment used is calibrated. If any result is out of specification, the batch should not be released. QA should also verify that the testing laboratory is qualified and that the data is reliable.